Patents by Inventor Gustavo Bounous

Gustavo Bounous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110251121
    Abstract: A cysteine-rich undenatured whey-derived protein formulation did not interfere with the tumor-cytotoxic effects of chemotherapy and radiation therapy and did not have a negative effect on the clinical outcome, that is, negatively affect survival and increase mortality. Indeed, use of a high-cysteine undenatured whey derived protein in the treatment of cancer patients resulted in an increase in patient survival.
    Type: Application
    Filed: June 21, 2011
    Publication date: October 13, 2011
    Applicant: 2458781 CANADA INC.
    Inventors: Wulf DROGE, Gustavo BOUNOUS, John H. MOLSON
  • Publication number: 20100069288
    Abstract: A cysteine-rich undenatured whey-derived protein formulation did not interfere with the tumor-cytotoxic effects of chemotherapy and radiation therapy and did not have a negative effect on the clinical outcome, that is, negatively affect survival and increase mortality. Indeed, use of a high-cysteine undenatured whey derived protein in the treatment of cancer patients resulted in an increase in patient survival.
    Type: Application
    Filed: September 12, 2008
    Publication date: March 18, 2010
    Inventors: Wulf Droge, Gustavo Bounous, John H. Molson
  • Patent number: 5888552
    Abstract: This invention relates to a method of treatment of patients having lesions resulting from cancer cells and to an application as an anti-cancer composition of undenatured whey protein concentrate.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: March 30, 1999
    Assignee: Immunotec Research Corporation Ltd.
    Inventors: Gustavo Bounous, Phil Gold
  • Patent number: 5456924
    Abstract: Undenatured whey protein concentrate is administered to HIV-seropositive individuals to elevate their blood mononuclear cells, glutathione (GSH) level, body weight and sense of well being. In addition T-helper cells concentration and their T-helper cells/T-suppressor cells ratio are slightly elevated.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: October 10, 1995
    Assignee: Immunotec Research Corporation Ltd.
    Inventors: Gustavo Bounous, Phil Gold
  • Patent number: 5451412
    Abstract: The present invention is concerned with a whey protein composition comprising a suitable concentration of whey protein concentrate wherein the whey protein concentrate contains proteins which are present in an essentially undenatured state and wherein the biological activity of the whey protein concentrate is dependent on the overall amino acid and small peptides pattern resulting from the contribution of all its protein components and a method of producing said whey protein composition. The invention also relates to several applications of said composition.
    Type: Grant
    Filed: June 29, 1993
    Date of Patent: September 19, 1995
    Assignee: Immunotech Research Corporation, Ltd.
    Inventors: Gustavo Bounous, Phil Gold, Patricia A. L. Kongshavn
  • Patent number: 5290571
    Abstract: The present invention is concerned with a whey protein composition comprising a suitable concentration of whey protein concentrate wherein the whey protein concentrate contains proteins which are present in an essentially undenatured state and wherein the biological activity of the whey protein concentrate is dependent on the overall amino acid and small peptides pattern resulting from the contribution of all its protein components and a method of producing said whey protein composition. The invention also relates to several applications of said composition.
    Type: Grant
    Filed: October 4, 1989
    Date of Patent: March 1, 1994
    Assignee: Immunotec Research Corporation, Ltd.
    Inventors: Gustavo Bounous, Phil Gold, Patricia A. L. Kongshavn
  • Patent number: 5230902
    Abstract: This invention provides a method of improving the humoral immune response or increasing the concentration levels of glutathione in mammals, which comprises administering orally to a mammal a therapeutically or a prophylactically effective amount of undenatured whey protein concentrate which has a biological activity based on the overall amino acid and associated small peptides pattern resulting from the contribution of all its protein components. A method for improving the humoral immune response in mammals also is disclosed which comprises administering orally to a mammal the combination of a vitamin supplement containing vitamin B.sub.2 in an amount in excess of minimum daily requirements and an effective amount of undenatured whey protein concentrate. This invention further provides a dietary supplement for a mammal which comprises an effective amount of vitamin B.sub.1, and B.sub.2 and a therapeutically or prophylactically effective amount of whey protein supplement.
    Type: Grant
    Filed: August 3, 1990
    Date of Patent: July 27, 1993
    Assignee: Immunotec Research Corporation
    Inventors: Phil Gold, Gustavo Bounous, Patricia A. L. Kongshavn